5-(tetradecyloxy)-2-furancarboxylic acid,
5-(tetradecyloxy)-2-furoic acid,
RMI 14514,
RMI-14514,
TOFA,
TOFA,
54857-86-2,
5-(Tetradecyloxy)-2-furoic acid,
5-(Tetradecyloxy)-2-furancarboxylic acid,
5-Tetradecyloxy-2-furonic acid,
Rmi 14514,
UNII-BI12FRY055,
2-Furancarboxylic acid, 5-(tetradecyloxy)-,
MDL 14514,
RMI-14514,
AC-8632,
BRN 0539681,
5-(tetradecyloxy)furan-2-carboxylic acid,
BI12FRY055,
CHEBI:77936,
C19H32O4,
RMI14514,
2-Furancarboxylic acid,5-(tetradecyloxy)-,
AC1L3GNQ,
AC1Q5UHU,
5-(tetradecyloxy)furoic acid,
SCHEMBL543676,
5-tetradecyloxy-2-furoic acid,
GTPL5280,
CHEMBL1562779,
TOFA, RMI 14514,
CTK5A2675,
DTXSID60203338,
CZRCFAOMWRAFIC-UHFFFAOYSA-N,
HMS3649D14,
5- (tetradecyloxy)-2-furoic acid,
BCP20578,
EX-A1198,
MDL14514,
TOFA, >=98% (HPLC),
2076AH,
5-tetradecoxyfuran-2-carboxylic acid,
IN1057,
MFCD01726059,
ZINC17654938,
AKOS015994758,
CS-6290,
SB17381,
SS-4313,
KS-0000185D,
NCGC00165908-01,
NCGC00165908-02,
LS-70187,
TOFA (5-(Tetradecyloxy)-2-furoic acid),
HY-101068,
FT-0769937,
SR-01000946703,
SR-01000946703-1,
Olumacostat,
D04TYK,
D0P7HI,
AR-1G5717,
CID115175,
C19-H32-O4,
RMI 14,514,
5-Tetradecyloxy-furan-2-carboxylic acid,
C014289,
Acetyl-coenzyme A carboxylase inhibitor (Parkinson's disease), Accera,
Acetyl-coenzyme A carboxylase inhibitor (Parkinson's disease), Neuera,
5659-20-1,